Wall Street Zen lowered shares of Innospec (NASDAQ:IOSP – Free Report) from a buy rating to a hold rating in a research note released on Saturday.
Innospec Price Performance
NASDAQ IOSP opened at $79.21 on Friday. The stock has a market capitalization of $1.97 billion, a PE ratio of 101.55 and a beta of 1.11. The business has a 50 day simple moving average of $83.42 and a two-hundred day simple moving average of $87.21. Innospec has a 1-year low of $74.10 and a 1-year high of $128.35.
Innospec (NASDAQ:IOSP – Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The specialty chemicals company reported $1.26 earnings per share for the quarter, beating the consensus estimate of $1.17 by $0.09. The business had revenue of $439.70 million during the quarter, compared to analysts’ expectations of $440.70 million. Innospec had a return on equity of 10.89% and a net margin of 1.08%.The firm’s revenue for the quarter was up 1.1% compared to the same quarter last year. During the same quarter last year, the business posted $1.39 EPS. On average, analysts anticipate that Innospec will post 6.18 EPS for the current fiscal year.
Hedge Funds Weigh In On Innospec
About Innospec
Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.
See Also
- Five stocks we like better than Innospec
- Dividend Capture Strategy: What You Need to Know
- How The Weak Dollar Is Fueling These Global Stock Surges
- Compound Interest and Why It Matters When Investing
- 3 Recession-Ready Stocks That Thrive When the Economy Sputters
- Russell 2000 Index, How Investors Use it For Profitable Trading
- 3 Automation-Focused Stocks Flying Under the Radar
Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.